THERABID Trademark

Trademark Overview


On Friday, April 21, 1972, a trademark application was filed for THERABID with the United States Patent and Trademark Office. The USPTO has given the THERABID trademark a serial number of 72422097. The federal status of this trademark filing is EXPIRED as of Saturday, May 29, 2004. This trademark is owned by MISSION PHARMACAL COMPANY. The THERABID trademark is filed in the Pharmaceutical Products category with the following description:

THERAPEUTIC MULTIVITAMIN COMBINATION

General Information


Serial Number72422097
Word MarkTHERABID
Filing DateFriday, April 21, 1972
Status900 - EXPIRED
Status DateSaturday, May 29, 2004
Registration Number0966889
Registration DateTuesday, August 28, 1973
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTHERAPEUTIC MULTIVITAMIN COMBINATION

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code9 - Expired
Class Status DateSaturday, May 29, 2004
Primary Code018
First Use Anywhere DateFriday, October 1, 1971
First Use In Commerce DateFriday, October 1, 1971

Trademark Owner History


Party NameMISSION PHARMACAL COMPANY
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN ANTONIO, TX 78296

Trademark Events


Event DateEvent Description
Saturday, May 29, 2004CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, April 29, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 12, 2002PAPER RECEIVED
Tuesday, July 13, 1993REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, May 20, 1993REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
Tuesday, September 25, 1979REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.